EGFR and small cell lung carcinoma: Several mechanisms of secondary resistance have been revealed, including: EGFR T790M mutation (the most frequent), mesenchymal-epithelial transition, MET amplification, phosphatidylinositol-4-5-bisphosphate 3-kinase mutations (PI3K) and small-cell lung cancer transformation [12–15].